English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Miltefosine (Impavido): the first oral treatment against leishmaniasis

Sindermann, H., Croft, S. L., Engel, K. R., Bommer, W., Eibl, H., Unger, C., et al. (2004). Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical Microbiology and Immunology, 193(4), 173-180. Retrieved from http://www.springerlink.com/content/qhh4kh9a38137u6h/fulltext.pdf.

Item is

Files

show Files
hide Files
:
219372.pdf (Publisher version), 0B
 
File Permalink:
-
Name:
219372.pdf
Description:
-
OA-Status:
Visibility:
Restricted (UNKNOWN id 303; )
MIME-Type / Checksum:
application/pdf
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Sindermann, H., Author
Croft, S. L., Author
Engel, K. R., Author
Bommer, W., Author
Eibl, H.1, Author           
Unger, C., Author
Engel, J., Author
Affiliations:
1Research Group of Phospholipids, MPI for biophysical chemistry, Max Planck Society, ou_578562              

Content

show
hide
Free keywords: visceral leishmaniasis; Miltefosine; oral activity; antimonial resistance
 Abstract: -

Details

show
hide
Language(s): eng - English
 Dates: 2004-11
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Medical Microbiology and Immunology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 193 (4) Sequence Number: - Start / End Page: 173 - 180 Identifier: -